Technical Analysis for SLP - Simulations Plus, Inc.

Grade Last Price % Change Price Change
F 27.58 -0.14% -0.04
SLP closed down 0.14 percent on Wednesday, November 20, 2024, on 86 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Low Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -0.14%
Narrow Range Bar Range Contraction -0.14%
Stochastic Reached Oversold Weakness -0.14%
Down 3 Days in a Row Weakness -0.14%
Down 4 Days in a Row Weakness -0.14%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 18 hours ago
60 Minute Opening Range Breakout about 20 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
New 52 Week Low about 22 hours ago
Down 1% about 23 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Simulations Plus, Inc. Description

Simulations Plus, Inc. designs and develops pharmaceutical simulation software for use in the pharmaceutical research and in the education of pharmacy and medical students. The company's products include ADMET Predictor, a computer program that takes molecular structures as inputs and predicts their properties; MedChem Designer, a molecule drawing program or sketcher; MedChem Studio, a tool for data mining and designing new drug-like molecules by medicinal and computational chemists; DDDPlus, which simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives contained in tablets and capsules; and GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals. It also develops and sells Abbreviate!, a productivity software program, as well as offers consulting and contract research services to the pharmaceutical industry. The company operates in North America, Europe, Asia, and South America. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.


Classification

Sector: Technology
Industry: Health Information Services
Keywords: Health Sciences Pharmacy Pharmacology In Vitro Pharmaceutical Sciences Lancaster Medicinal Chemistry Pharmacokinetics Software Program Simulation Software Contract Research Services Data Mining Pharmaceutical Research

Is SLP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 51.1426
52 Week Low 27.0652
Average Volume 197,251
200-Day Moving Average 39.88
50-Day Moving Average 30.86
20-Day Moving Average 29.60
10-Day Moving Average 29.92
Average True Range 1.21
RSI (14) 36.31
ADX 23.15
+DI 20.26
-DI 36.15
Chandelier Exit (Long, 3 ATRs) 31.12
Chandelier Exit (Short, 3 ATRs) 30.70
Upper Bollinger Bands 32.80
Lower Bollinger Band 26.41
Percent B (%b) 0.18
BandWidth 21.58
MACD Line -0.79
MACD Signal Line -0.57
MACD Histogram -0.2188
Fundamentals Value
Market Cap 550.69 Million
Num Shares 20 Million
EPS 0.53
Price-to-Earnings (P/E) Ratio 52.04
Price-to-Sales 13.33
Price-to-Book 4.81
PEG Ratio 9.77
Dividend 0.24
Dividend Yield 0.87%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.57
Resistance 3 (R3) 28.51 28.12 28.40
Resistance 2 (R2) 28.12 27.86 28.15 28.35
Resistance 1 (R1) 27.85 27.71 27.98 27.91 28.29
Pivot Point 27.46 27.46 27.52 27.49 27.46
Support 1 (S1) 27.19 27.20 27.32 27.25 26.87
Support 2 (S2) 26.80 27.05 26.83 26.81
Support 3 (S3) 26.53 26.80 26.76
Support 4 (S4) 26.59